Modifiable contributing factors to COVID-19: A comprehensive review
19.12.2022
Vitiligo induced by immune checkpoint inhibitors
in melanoma patients: an expert opinion
Janny E.
10.05.2021
Emerging roles of coronavirus in autoimmune diseases
28.04.2021
Infusion of anti-DFS70 antibodies
prolonged survival of lupus-prone mice
20.04.2021
Use of Rescue Therapy with IVIG or Cyclophosphamide
in Juvenile Myositis
20.04.2021
Fibromyalgia in women: somatisation or stress-evoked, sex-dimorphic neuropathic pain?
20.04.2021
Autoimmune Concept of Schizophrenia: Historical Roots and Current Facets
05.04.2021
Systemic lupus erythematosus (SLE), the embodiment of a multi-organ autoimmune disease, results from hyperactivation of host-defence pathways and immune recognition of the most fundamental building blocks of life. In 2018, key advances have placed intestinal immunity and dysregulated expansions of candidate pathobionts at the forefront of SLE pathogenesis.
11.01.2021
The Microbiome and Systemic Lupus Erythematosus
11.01.2021
Systemic Lupus Erythematosus and dysbiosis in the
microbiome: cause or effect or both?
11.01.2021